000			02078 a2200685 4500
005			20250513044314.0
264		0	_c19950203
008			199502s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aSan Miguel, J F
245	0	0	_aA new staging system for multiple myeloma based on the number of S-phase plasma cells. _h[electronic resource]
260			_bBlood _cJan 1995
300			_a448-55 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aADP-ribosyl Cyclase
650	0	4	_aADP-ribosyl Cyclase 1
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntigens, CD
650	0	4	_aAntigens, Differentiation _xanalysis
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAsparaginase _xadministration & dosage
650	0	4	_aBone Marrow _xpathology
650	0	4	_aBone Marrow Examination
650	0	4	_aCohort Studies
650	0	4	_aDNA, Neoplasm _xanalysis
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aHumans
650	0	4	_aLife Tables
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins
650	0	4	_aMercaptopurine _xadministration & dosage
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMitotic Index
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNeoplasm Staging _xmethods
650	0	4	_aPlasma Cells _xpathology
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aRisk Factors
650	0	4	_aS Phase
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xadministration & dosage
650	0	4	_abeta 2-Microglobulin _xanalysis
700	1		_aGarcía-Sanz, R
700	1		_aGonzález, M
700	1		_aMoro, M J
700	1		_aHernández, J M
700	1		_aOrtega, F
700	1		_aBorrego, D
700	1		_aCarnero, M
700	1		_aCasanova, F
700	1		_aJiménez, R
773	0		_tBlood _gvol. 85 _gno. 2 _gp. 448-55
999			_c7811356 _d7811356